Primary ambulatory thromboprophylaxis in patients with pancreatic cancer receiving chemotherapy: hope or hype?

Autor:	Htut, Thura Win, Thein, Kyaw Zin, Aung, Kyaw Lwin, Oo, Thein Hlaing
Předmět:	THROMBOLYTIC therapy THROMBOEMBOLISM prevention PANCREATIC tumors VEINS ANTICOAGULANTS THROMBOEMBOLISM TUMORS DISEASE complications
Zdroj:	Supportive Care in Cancer; Oct2022, Vol. 30 Issue 10, p8511-8517, 7p
Abstrakt:	Thrombosis is the second leading cause of death in cancer patients. Patients with pancreatic cancer (PC) have a very high risk of developing venous thromboembolism (VTE). Even though primary ambulatory thromboprophylaxis (PATP) could decrease this risk, there are uncertain issues with regard to the choice and dose of anticoagulants, duration of anticoagulant therapy, and patient selection criteria. In addition, the current practice guidelines on PATP in PC patients are equivocal. This review critically appraises the evidence on the use of PATP in PC patients receiving chemotherapy. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink